CRSP Operating Expenses
Crispr Therapeutics Ag · Operating Expenses
CRSP Operating Expenses
Latest reported$326.38Mperiod ending
CRSP TTM Operating Expenses ($23.37M → $326.38M)
TTM operating expenses
High-resolution chart · PNG
CRSP operating expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Expenses (USD) |
|---|---|
| 326,381,000 | |
| 330,186,000 | |
| 340,509,000 | |
| 343,833,000 | |
| 370,357,000 | |
| 380,948,000 | |
| 378,460,000 | |
| 389,289,000 | |
| 403,499,000 | |
| 429,285,000 | |
| 462,288,000 | |
| 476,595,000 | |
| 511,229,000 | |
| 540,138,000 | |
| 563,347,000 | |
| 462,301,000 | |
| 425,392,000 | |
| 386,535,000 | |
| 335,831,000 | |
| 337,919,000 | |
| 252,744,000 | |
| 163,458,000 | |
| 88,208,000 | |
| 79,714,000 | |
| 130,940,000 | |
| 164,888,000 | |
| 194,089,000 | |
| 222,160,000 | |
| 199,390,000 | |
| 182,463,000 | |
| 162,067,000 | |
| 148,077,000 | |
| 124,039,000 | |
| 110,553,000 | |
| 105,645,000 | |
| 101,946,000 | |
| 92,148,000 | |
| 84,613,000 | |
| 73,294,000 | |
| 58,053,000 | |
| 48,096,000 | |
| 32,853,000 | |
| 23,368,000 |